In Brief: Ciba-Geigy's Transderm-Nitro
Executive Summary
Ciba-Geigy's Transderm-Nitro: Transdermal nitroglycerin patch (NDA 20-144) receives DESI upgrade to full approval for prevention of angina Feb. 27. Transderm-Nitro has been available under a conditionally approved NDA following FDA's July 1993 announcement that manufacturers of DESI coronary vasodilator products must submit NDAs. Transderm-Nitro is approved in .1, .2, .4, .6 and .8 mg/hour strengths. Schering-Plough's Nitro-Dur received a DESI upgrade last April...